Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 cases

Ann Diagn Pathol. 2019 Apr:39:63-68. doi: 10.1016/j.anndiagpath.2019.02.008. Epub 2019 Feb 10.

Abstract

Hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinoma (HLRCC)/fumarate hydratase deficient renal cell carcinoma (FHRCC) is defined by molecular genetic changes (mutation/LOH in fumarate hydratase (FH) gene). We investigated chromosomal numerical aberration pattern (CNV) in FHRCC/HLRCC using array comparative genomic hybridization analysis and low pass whole genome sequencing. Genetic analysis was successfully completed in 12 tumors. Most common chromosomal aberrations detected were a complete or partial loss of chromosome 4 (5/12 cases), chromosome 15 (4/12 cases), and chromosomes 9, 13, and 14 (each in 3/12 cases), as well as a complete or partial gain of chromosome 17 (in 4/12 cases). No chromosomal losses or gains were detected in 4 cases. Copy number variation pattern in FHRCC/HLRCC appears to be highly variable and does not provide a useful diagnostic tool in identifying these cases. Immunohistochemical staining and especially molecular genetic evaluation of FH gene mutations/LOH remain the gold standard in identifying FHRCC/HLRCC.

Keywords: Chromosomal numerical aberration pattern; Fumarate hydratase deficient renal cell carcinoma; Kidney.

MeSH terms

  • Adult
  • Carcinoma, Renal Cell / genetics*
  • Chromosome Aberrations*
  • Comparative Genomic Hybridization
  • DNA Copy Number Variations
  • Female
  • Fumarate Hydratase / deficiency*
  • Humans
  • Kidney Neoplasms / genetics*
  • Loss of Heterozygosity
  • Male
  • Middle Aged
  • Whole Genome Sequencing

Substances

  • Fumarate Hydratase